Arizona 57th Legislature - Second Regular Session Status: Passed Senate 1 R cosponsors

SB 1458 — pharmacy board; civil penalties

Last action — DPA/SE

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 57th Legislature - Second Regular Session. It reached “Passed Senate” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there are no live odds of enactment. It would have to be reintroduced in the current session to move again.

Bill Text

What changed in the latest version

434 added · 91 removed

Plain-language change summary

The recent amendments to SB 1458 introduce new provisions aimed at regulating pharmacy benefit managers (PBMs) in Arizona. Specifically, these changes include a prohibition against PBMs transferring patient or prescriber identifiable prescription information for commercial purposes and preventing them from steering patients toward their affiliated providers. These changes are important because they enhance patient privacy and ensure that patients have the freedom to choose their pharmacies without undue influence from PBMs, ultimately promoting fairer competition and better healthcare choices.

→
Previous
Latest
Fifty-seventh Legislature Health & Human Services Second Regular Session S.B.
Senate Engrossed pharmacy board;
1458 PROPOSED HOUSE OF REPRESENTATIVES AMENDMENTS TO S.B.
civil penalties State of Arizona Senate Fifty-seventh Legislature Second Regular Session SENATE BILL 1458 AN ACT AMENDING SECTIONS 32-1904 AND 32-1927.02, ARIZONA REVISED STATUTES;
1458 (Reference to Senate engrossed bill) Strike everything after the enacting clause and insert:
RELATING TO THE ARIZONA STATE BOARD OF PHARMACY.
"Section 1.
(TEXT OF BILL BEGINS ON NEXT PAGE) - i - S.B.
Title 20, chapter 25, article 2, Arizona Revised Statutes, is amended by adding section 20-3337, to read:
1458 Be it enacted by the Legislature of the State of Arizona:
20-3337.
Section 1.
Pharmacy benefit managers;
Section 32-1904, Arizona Revised Statutes, is amended to read:
affiliated providers;
32-1904.
prohibition against steering;
Powers and duties of board;
definition A.
immunity A.
A PHARMACY BENEFIT MANAGER MAY NOT TRANSFER TO OR RECEIVE FROM ITS AFFILIATED PROVIDER A RECORD THAT CONTAINS PATIENT OR PRESCRIBER IDENTIFIABLE PRESCRIPTION INFORMATION FOR A COMMERCIAL PURPOSE.
The board shall:
FOR THE PURPOSES OF THIS SUBSECTION, COMMERCIAL PURPOSE DOES NOT INCLUDE ANY OF THE FOLLOWING:
PHARMACY REIMBURSEMENT.
Make bylaws and adopt rules that are necessary to protect the public and that pertain to the practice of pharmacy, the manufacturing, wholesaling or supplying of drugs, devices, poisons or hazardous substances, the use of pharmacy technicians and support personnel and the lawful performance of its duties.
FORMULARY COMPLIANCE.
Fix standards and requirements to register and reregister pharmacies, except as otherwise specified.
PHARMACEUTICAL CARE.
Investigate compliance as to the quality, label and labeling of all drugs, devices, poisons or hazardous substances and take action necessary to prevent the sale of these if they do not conform to the standards prescribed in this chapter, the official compendium or the federal act.
UTILIZATION REVIEW BY A HEALTH CARE PROVIDER OR A PUBLIC HEALTH ACTIVITY THAT IS AUTHORIZED BY LAW.
Enforce its rules.
In so doing, the board or its agents have free access, during the hours reported with the board or the posted hours at the facility, to any pharmacy, manufacturer, wholesaler, third-party logistics provider, nonprescription drug permittee or other establishment in which drugs, devices, poisons or hazardous substances are manufactured, processed, packed or held, or to enter any vehicle being used to transport or hold such drugs, devices, poisons or hazardous substances for the purpose of:
(a) Inspecting the establishment or vehicle to determine whether any provisions of this chapter or the federal act are being violated.
(b) Securing samples or specimens of any drug, device, poison or hazardous substance after paying or offering to pay for the sample.
(c) Detaining or embargoing a drug, device, poison or hazardous substance in accordance with section 32-1994.
5.
Examine and license as pharmacists and pharmacy interns all qualified applicants as provided by this chapter.
6.
Require each applicant for an initial license to apply for a fingerprint clearance card pursuant to section 41-1758.03.
If an applicant is issued a valid fingerprint clearance card, the applicant shall submit the valid fingerprint clearance card to the board with the completed application.
If an applicant applies for a fingerprint clearance card and is denied, the applicant may request that the board consider the application for licensure notwithstanding the absence of a valid fingerprint clearance card.
The board, in its discretion, may approve an application for licensure despite the denial of a valid fingerprint clearance card if the board determines that the applicant's criminal history information on which the denial was based does not alone disqualify the applicant from licensure.
- 1 - S.B.
1458 7.
Issue duplicates of lost or destroyed permits on the payment of a fee as prescribed by the board.
8.
Adopt rules to rehabilitate pharmacists and pharmacy interns as provided by this chapter.
9.
At least once every three months, notify pharmacies regulated pursuant to this chapter of any modifications on prescription writing privileges of podiatrists, dentists, doctors of medicine, registered nurse practitioners, osteopathic physicians, veterinarians, physician assistants, optometrists and homeopathic physicians of which it receives notification from the state board of podiatry examiners, state board of dental examiners, Arizona medical board, Arizona state board of nursing, Arizona board of osteopathic examiners in medicine and surgery, Arizona state veterinary medical examining board, Arizona regulatory board of physician assistants, state board of optometry or board of homeopathic and integrated medicine examiners.
10.
Charge a permittee a fee, as determined by the board, for an inspection if the permittee requests the inspection.
11.
Issue only one active or open license per individual.
12.
Allow a licensee to regress to a lower level license on written explanation and review by the board for discussion, determination and possible action.
Show all 235 changed rows (195 more)
Previous
Latest
13.
Open an investigation only if the identifying information regarding a complainant is provided or the information provided is sufficient to conduct an investigation.
14.
Provide notice to an applicant, licensee or permittee using only the information provided to the board through the board's licensing database.
A PHARMACY BENEFIT MANAGER MAY NOT DIRECTLY OR INDIRECTLY STEER A PATIENT TO USE THE PHARMACY BENEFIT MANAGER'S AFFILIATED PROVIDER BY DOING ANY OF THE FOLLOWING:
The board may:
COMMUNICATING THROUGH DATA MINING OR OTHER SIMILAR PROCESSES OF PATIENT INFORMATION THAT ARE GENERATED FROM OR OBTAINED THROUGH THE PRESCRIPTION FILLING PROCESS AT A PHARMACY, INCLUDING:
Employ chemists, compliance officers, clerical help and other employees subject to title 41, chapter 4, article 4 and provide laboratory facilities for the proper conduct of its business.
(a) CONTACTING THE PATIENT VERBALLY OR IN WRITING TO INFLUENCE THE PATIENT DIRECTLY OR INDIRECTLY.
(b) PROVIDING A PATIENT WITH THE OPTION TO USE AN ALTERNATIVE PHARMACY THAT IS A PHARMACY BENEFIT MANAGER'S AFFILIATED PROVIDER.
ATTEMPTING TO INFLUENCE A PATIENT TO USE AN AFFILIATED PROVIDER.
Provide, by educating and informing the licensees and the public, assistance in curtailing abuse in the use of drugs, devices, poisons and hazardous substances.
RETALIATING AGAINST A PATIENT WHO DOES NOT USE AN AFFILIATED PROVIDER.
Approve or reject the manner of storage and security of drugs, devices, poisons and hazardous substances.
4.
Accept monies and services to assist in enforcing this chapter from other than licensees:
(a) For performing inspections and other board functions.
(b) For the cost of copies of the pharmacy and controlled substances laws, the annual report of the board and other information from the board.
5.
Adopt rules for professional conduct appropriate to the establishment and maintenance of a high standard of integrity and dignity in the profession of pharmacy.
- 2 - S.B.
1458 6.
Grant permission to deviate from a state requirement for modernization of pharmacy practice, experimentation or technological advances.
7.
Adopt rules for the training and practice of pharmacy interns, pharmacy technicians and support personnel.
8.
Investigate alleged violations of this chapter, conduct hearings in respect to violations, subpoena witnesses and take such action as it deems necessary to revoke or suspend a license, A REGISTRATION or a permit, place a licensee, REGISTRANT or permittee on probation or warn a licensee, REGISTRANT or permittee under this chapter or to bring notice of violations to the county attorney of the county in which a violation took place or to the attorney general.
9.
By rule, approve colleges or schools of pharmacy.
10.
By rule, approve programs of practical experience, clinical programs, internship training programs, programs of remedial academic work and preliminary equivalency examinations as provided by this chapter.
11.
Assist in the continuing education of pharmacists and pharmacy interns.
12.
Issue inactive status licenses as provided by this chapter.
13.
Accept monies and services from the federal government or others for educational, research or other purposes pertaining to the enforcement of this chapter.
14.
By rule, except from the application of all or any part of this chapter any material, compound, mixture or preparation containing any stimulant or depressant substance included in section 13-3401, paragraph 6, subdivision (c) or (d) from the definition of dangerous drug if the material, compound, mixture or preparation contains one or more active medicinal ingredients not having a stimulant or depressant effect on the central nervous system, provided that such admixtures are included in such combinations, quantity, proportion or concentration as to vitiate the potential for abuse of the substances that do have a stimulant or depressant effect on the central nervous system.
15.
Adopt rules for the revocation, suspension or reinstatement of licenses, REGISTRATIONS or permits or the probation of licensees, REGISTRANTS or permittees as provided by this chapter.
16.
Issue a certificate of free sale to any person that is licensed by the board as a manufacturer for the purpose of manufacturing or distributing food supplements or dietary supplements as defined in rule by the board and that wants to sell food supplements or dietary supplements domestically or internationally.
The application shall contain all of the following:
(a) The applicant's name, address, email address, telephone and fax number.
(b) The product's full, common or usual name.
- 3 - S.B.
1458 (c) A copy of the label for each product listed.
If the product is to be exported in bulk and a label is not available, the applicant shall include a certificate of composition.
(d) The country of export, if applicable.
(e) The number of certificates of free sale requested.
17.
Establish an inspection process to issue certificates of free sale or good manufacturing practice certifications.
The board shall establish in rule:
(a) A fee to issue certificates of free sale.
(b) A fee to issue good manufacturing practice certifications.
(c) An annual inspection fee.
18.
Delegate to the executive director the authority to:
(a) If the president or vice president of the board concurs after reviewing the case, enter into an interim consent agreement with a licensee or permittee if there is evidence that a restriction against the license or permit is needed to mitigate danger to the public health and safety.
The board may subsequently formally adopt the interim consent agreement with any modifications the board deems necessary.
(b) Take no action or dismiss a complaint that has insufficient evidence that a violation of statute or rule governing the practice of pharmacy occurred.
(c) Request an applicant or licensee to provide court documents and police reports if the applicant or licensee has been charged with or convicted of a criminal offense.
The executive director may do either of the following if the applicant or licensee fails to provide the requested documents to the board within thirty business days after the request:
(i) Close the application, deem the application fee forfeited and not consider a new application complete unless the requested documents are submitted with the application.
(ii) Notify the licensee of an opportunity for a hearing in accordance with section 41-1061 to consider suspension of the licensee.
(d) Pursuant to section 36-2604, subsection B, review prescription information collected pursuant to title 36, chapter 28, article 1.
SUBSECTION B OF THIS SECTION DOES NOT PREVENT A PHARMACY BENEFIT MANAGER FROM INCLUDING ITS AFFILIATED PROVIDER IN A PATIENT OR PROSPECTIVE PATIENT COMMUNICATION IF THE COMMUNICATION BOTH:
At each regularly scheduled board meeting, the executive director shall provide to the board a list of the executive director's actions taken pursuant to subsection B, paragraph 18, subdivisions (a), (c) and (d) (b) AND (c) of this section since the last board meeting.
D.
The board may issue nondisciplinary civil penalties or delegate to the executive director the authority to issue nondisciplinary civil penalties.
The nondisciplinary civil penalties shall be prescribed by the board in rule and issued using a board-approved form.
THE MAXIMUM CIVIL PENALTY MAY NOT EXCEED $25,000 IN ANY SIX-MONTH PERIOD.
THE BOARD AND THE EXECUTIVE DIRECTOR MAY ISSUE A CIVIL PENALTY THAT IS LESS THAN THE MAXIMUM CIVIL PENALTY AND MAY TAKE INTO ACCOUNT ACTIVITIES OF THE LICENSEE, REGISTRANT OR PERMITTEE OVER THE PREVIOUS FORTY-EIGHT MONTHS.
If a - 4 - S.B.
1458 licensee, REGISTRANT or permittee fails to pay a nondisciplinary civil penalty that the board has imposed on it, the board shall hold a hearing on the matter.
In addition to any other nondisciplinary civil penalty adopted by the board, either of the following acts or omissions that is not an imminent threat to the public health and safety is subject to a nondisciplinary civil penalty:
REGARDS INFORMATION ABOUT THE COST OR SERVICE PROVIDED BY PHARMACIES OR DURABLE MEDICAL EQUIPMENT PROVIDERS IN THE NETWORK OF A HEALTH BENEFITS PLAN IN WHICH THE PATIENT OR PROSPECTIVE PATIENT IS ENROLLED.
An occurrence of either of the following:
(a) Failing to submit a remodel application before remodeling a permitted facility.
(b) Failing to notify the board of the relocation of a business.
INCLUDES ACCURATE COMPARABLE INFORMATION REGARDING PHARMACIES OR DURABLE MEDICAL EQUIPMENT PROVIDERS IN THE NETWORK THAT ARE NOT THE ISSUER'S OR PHARMACY BENEFIT MANAGER'S AFFILIATED PROVIDERS.
The occurrence of any of the following violations or any of the violations adopted by the board in rule, with three or more violations being presented to the board as a complaint:
D.
(a) The licensee, REGISTRANT or permittee fails to update the licensee's, REGISTRANT'S or permittee's online profile within ten days after a change in contact information, address, telephone number or email address.
A PHARMACY BENEFIT MANAGER MAY NOT DO ANY OF THE FOLLOWING:
(b) The licensee OR REGISTRANT fails to update the licensee's OR REGISTRANT'S online profile within ten days after a change in employment.
House Amendments to S.B.
(c) The licensee fails to complete the required continuing education for a license renewal.
1458 1.
(d) The licensee fails to update the licensee's online profile to reflect a new pharmacist in charge within fourteen days after the position change.
PENALIZE A BENEFICIARY OR PROVIDE AN INDUCEMENT TO THE BENEFICIARY FOR THE PURPOSES OF GETTING THE BENEFICIARY TO USE A SPECIFIC RETAIL, MAIL ORDER OR OTHER NETWORK PHARMACY THAT IS THE PHARMACY BENEFIT MANAGER'S AFFILIATED PROVIDER.
(e) The permittee fails to update the permittee's online profile to reflect a new designated representative within ten days after the position change.
FOR THE PURPOSES OF THIS PARAGRAPH, "INDUCEMENT" MEANS PROVIDING FINANCIAL INCENTIVES, INCLUDING VARIATIONS IN PREMIUMS, DEDUCTIBLES, COPAYMENTS OR COINSURANCE.
(f) The licensee, REGISTRANT or permittee fails to notify the board of a new criminal charge, arrest or conviction against the licensee, REGISTRANT or permittee in this state or any other jurisdiction.
(g) The licensee, REGISTRANT or permittee fails to notify the board of a disciplinary action taken against the licensee, REGISTRANT or permittee by another regulating agency in this state or any other jurisdiction.
(h) A THE licensee, REGISTRANT or permittee fails to renew a license or permit within sixty days after the license, REGISTRATION or permit expires.
If more than sixty days have lapsed after the expiration of a license or permit, the licensee, REGISTRANT or permittee shall appear before the board.
(i) A new pharmacist in charge fails to conduct a controlled substance inventory within ten days after starting the position.
(j) A person fails to obtain a permit before shipping into this state anything that requires a permit pursuant to this chapter.
(k) Any other violations of statute or rule that the board or the board's designee deems appropriate for a nondisciplinary civil penalty.
- 5 - S.B.
1458 E.
The board shall develop substantive policy statements pursuant to section 41-1091 for each specific licensing and regulatory authority the board delegates to the executive director.
F.
The executive director and other personnel or agents of the board are not subject to civil liability for any act done or proceeding undertaken or performed in good faith and in furtherance of the purposes of this chapter.
Sec.
SOLICIT A PATIENT OR PRESCRIBER TO TRANSFER A PATIENT PRESCRIPTION TO THE PHARMACY BENEFIT MANAGER'S AFFILIATED PROVIDER.
Section 32-1927.02, Arizona Revised Statutes, is amended to read:
32-1927.02.
Permittees;
disciplinary action A.
The board may discipline a permittee if:
1.
The board determines that the permittee or permittee's employee is guilty of unethical conduct pursuant to section 32-1901.01, subsection A.
2.
Pursuant to a psychiatric examination, the permittee or the permittee's employee is found to be mentally unfit to safely engage in employment duties.
REQUIRE A PHARMACY OR DURABLE MEDICAL EQUIPMENT PROVIDER THAT IS NOT THE PHARMACY BENEFIT MANAGER'S AFFILIATED PROVIDER TO TRANSFER A PATIENT'S PRESCRIPTION TO THE PHARMACY BENEFIT MANAGER'S AFFILIATED PROVIDER WITHOUT THE PRIOR WRITTEN CONSENT OF THE PATIENT.
The board determines that the permittee or the permittee's employee is physically or mentally incapacitated to such a degree as to render the permittee or permittee's employee unfit to safely engage in employment duties.
THIS PARAGRAPH DOES NOT PROHIBIT A PATIENT FROM PERSONALLY REQUESTING TO TRANSFER THE PATIENT'S PRESCRIPTION WITHOUT WRITTEN CONSENT.
PAY AN AFFILIATED PROVIDER A REIMBURSEMENT AMOUNT THAT IS MORE THAN THE AMOUNT THE PHARMACY BENEFIT MANAGER PAYS A PHARMACY OR DURABLE MEDICAL EQUIPMENT PROVIDER THAT IS NOT AN AFFILIATED PROVIDER FOR THE SAME PRODUCT OR SERVICE.
The permit was issued through error.
COMMIT ANY UNFAIR AND DECEPTIVE TRADE PRACTICE THAT IS PROHIBITED BY SECTION 44-1522.
A permittee or permittee's employee allows a person who does not possess a current license or registration issued by the board to work as a pharmacist, pharmacy intern, pharmacy technician or pharmacy technician trainee.
B.
A permittee who after a formal hearing is found by the board to be guilty of unethical conduct, to be mentally or physically unable safely to engage in employment duties or to be in violation of this chapter or a rule adopted under this chapter or whose employee after a formal hearing is found by the board to be guilty of unethical conduct, to be mentally or physically unable safely to engage in employment duties or to be in violation of this chapter or a rule adopted under this chapter is subject to any one or combination of the following:
1.
A civil penalty of not more than $1,000 for each violation of this chapter or a rule adopted under this chapter.
FOR PERMITTEES THAT ARE NOT DIRECTLY PERFORMING PATIENT CARE, CIVIL PENALTIES IMPOSED PURSUANT TO THIS PARAGRAPH MAY NOT EXCEED $25,000 IN THE AGGREGATE IN ANY SIX-MONTH PERIOD.
2.
A letter of reprimand.
3.
A decree of censure.
4.
Completion of board-designated pharmacy law continuing education courses.
5.
Probation.
6.
Suspension or revocation of the permit.
- 6 - S.B.
1458 C.
The board may charge the costs of formal hearings to the permittee whom it finds to be in violation of this chapter or a rule adopted under this chapter or whose employee it finds to be in violation of this chapter or a rule adopted under this chapter.
D.
The board on its own motion may investigate any evidence that appears to show that a permittee or permittee's employee is or may be guilty of unethical conduct, is or may be mentally or physically unable safely to engage in employment duties or is or may be in violation of this chapter or a rule adopted under this chapter.
Any person may, and any licensee or permittee must, report to the board any information that appears to show that a permittee or permittee's employee is or may be guilty of unethical conduct, is or may be mentally or physically unable safely to engage in employment duties or is or may be in violation of this chapter or a rule adopted under this chapter.
The board or the executive director shall notify the permittee as to the content of the complaint as soon as reasonable.
Any person or entity that reports or provides information to the board in good faith is not subject to an action for civil damages.
It is an act of unethical conduct for any permittee to fail to report as required by this subsection.
THE PROHIBITIONS IN THIS SECTION APPLY TO A PHARMACY BENEFIT MANAGER ACTING ON ITS OWN BEHALF OR ON BEHALF OF AN INSURER.
The board or, if delegated by the board, the executive director shall require any combination of mental, physical, psychological, psychiatric or medical competency examinations and conduct necessary investigations, including investigational interviews between representatives of the board and the permittee or permittee's employee, to fully inform itself about any information filed with the board under subsection D of this section.
These examinations may also include biological fluid testing.
The board may require the permittee or permittee's employee, at that person's expense, to undergo assessment by a board-approved substance abuse treatment and rehabilitation program.
THIS SECTION DOES NOT APPLY TO HEALTH AND ACCIDENT INSURANCE COVERAGE THAT IS OBTAINED BY THE DEPARTMENT OF ADMINISTRATION UNDER SECTION 38-651.
If after completing its investigation the board finds that the information provided pursuant to subsection D of this section is not of sufficient seriousness to merit disciplinary action against the permit, the board may take any of the following actions:
1.
Dismiss if the complaint is without merit.
2.
File an advisory letter.
The permittee may file a written response with the board within thirty days after receiving the advisory letter.
3.
Require the permittee to complete board-designated pharmacy law continuing education courses.
THE DEPARTMENT MAY INVESTIGATE VIOLATIONS OF THIS SECTION.
The board shall not disclose the name of the person who provides information regarding a permittee's or permittee's employee's drug or alcohol impairment or the name of the person who files a complaint if that person requests anonymity.
ANY CONDUCT IN VIOLATION OF THIS SECTION THAT IS PERFORMED WITH SUCH A FREQUENCY AS TO INDICATE A GENERAL BUSINESS PRACTICE CONSTITUTES AN UNLAWFUL PRACTICE UNDER SECTION 44-1522 AND IS SUBJECT TO THE CONSUMER FRAUD PROVISIONS UNDER TITLE 44, CHAPTER 10, ARTICLE 7.
FOR THE PURPOSES OF THIS SECTION, "AFFILIATED PROVIDER" MEANS A PHARMACY OR DURABLE MEDICAL EQUIPMENT PROVIDER THAT DIRECTLY, OR INDIRECTLY THROUGH ONE OR MORE INTERMEDIARIES, CONTROLS, IS CONTROLLED BY OR UNDER COMMON CONTROL WITH A PHARMACY BENEFIT MANAGER.
If after completing its investigation the board believes that the information is or may be true, it may request a conference with the - 7 - S.B.
Sec.
1458 permittee or permittee's employee.
If the permittee or permittee's employee refuses the invitation for a conference and the investigation indicates that grounds may exist for revocation or suspension of a permit, probation, issuance of a decree of censure or a letter of reprimand or imposition of a civil penalty, the board shall issue a formal notice that a hearing be held pursuant to title 41, chapter 6, article 10.
I.
If through information provided pursuant to subsection D of this section or by other means the board finds that the protection of the public health, welfare and safety requires emergency action against the permit, the board may restrict a permit or order a summary suspension of a permit pending proceedings for revocation or other action.
If the board acts pursuant to this subsection, the board shall also serve the permittee with a written notice of complaint and formal hearing that sets forth the charges and the permittee's right to a formal hearing on the charges before the board or an administrative law judge within sixty days pursuant to title 41, chapter 6, article 10.
J.
If after completing the conference the board finds the information provided pursuant to subsection D of this section is not of sufficient seriousness to merit revocation or suspension of a permit, probation, issuance of a decree of censure or a letter of reprimand or imposition of a civil penalty, it may take the following actions:
1.
Dismiss if the information is without merit.
Applicability Section 20-3337, Arizona Revised Statutes, as added by this act, applies to contracts that are entered into, amended, extended or renewed on or after the effective date of this act." Amend title to conform SELINA BLISS 1458BLISS SE.docx 03/17/2026 3:24 PM C:
File an advisory letter.
SK 130VSRJGU -2-
The permittee may file a written response with the board within thirty days after receiving the advisory letter.
3.
Require the permittee to complete board-designated pharmacy law continuing education courses.
K.
If during a conference the board finds that the information provided pursuant to subsection D of this section indicates that grounds may exist for revocation or suspension of a permit, probation, issuance of a decree of censure or a letter of reprimand or imposition of a civil penalty, it may take the following actions:
1.
Dismiss if the information is without merit.
2.
File an advisory letter.
The permittee may file a written response with the board within thirty days after the permittee receives the advisory letter.
3.
Require the permittee to complete board-designated pharmacy law continuing education courses.
4.
Enter into an agreement with the permittee to discipline the permittee, restrict the permittee's business activities or rehabilitate or assess the permittee in order to protect the public and ensure the permittee's ability to safely engage in employment duties.
The agreement may include, at a minimum, the following disciplinary actions, business activity restrictions and rehabilitative or assessment programs:
(a) Issuance of a letter of reprimand.
- 8 - S.B.
1458 (b) Issuance of a decree of censure.
(c) Business activity restrictions, including limitations on the number, type, classification or schedule of drug, device, poison, hazardous substance, controlled substance or precursor chemical that may be manufactured, sold, distributed or dispensed.
(d) Successful completion of board-designated pharmacy law continuing education courses.
(e) Rehabilitative or assessment programs, including board-approved community service or successful completion of a board-approved substance abuse treatment and rehabilitation program at the permittee's own expense.
(f) A civil penalty of not more than $1,000 for each violation of this chapter or a rule adopted under this chapter.
(g) A period and terms of probation best adapted to protect the public health and safety and rehabilitate or assess the permittee concerned.
Probation may include temporary suspension and any or all of the disciplinary actions, business practice restrictions, rehabilitative or assessment programs listed in this section or any other program agreed to by the board and the permittee.
L.
If the board finds that the information provided pursuant to subsection D of this section and additional information provided during the conference indicate that grounds may exist for revocation or suspension of a permit, probation, issuance of a decree of censure or a letter of reprimand or imposition of a civil penalty, it shall initiate formal proceedings pursuant to title 41, chapter 6, article 10.
M.
If the permittee wishes to be present at the formal hearing in person or by representation, or both, the permittee must file with the board an answer to the charges in the notice of hearing.
The answer must be in writing, be verified under oath and be filed within thirty days after service of the notice of hearing.
Failure to answer the board's notice of hearing is deemed an admission of the charges in the notice of hearing.
N.
If the board, during any investigation, determines that a criminal violation might have occurred, it shall disclose its investigative evidence and information to the appropriate criminal justice agency for its consideration.
O.
In determining the appropriate disciplinary action under this section, the board shall consider all previous nondisciplinary and disciplinary actions against a permittee.
P.
The board may deny a permit to an applicant for the grounds prescribed in subsection A of this section.
Q.
If the board approves a permit and the business fails to become operational within nine months after the date the permit is granted, the permit is no longer valid.
The board may grant a onetime extension for the business to become operational.
- 9 -
⬇ Download PDF
View plain text versions (3)

Action History

  1. DPA/SE

  2. House Second Reading

  3. House First Reading.

  4. Transmit to House

  5. PASSED

  6. DP

  7. Senate Second Reading

  8. Senate First Reading

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 92 not signed on · 1 voted No

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (92)

92 members have not signed on to this bill.

Show all 92 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Passed

Passed 29 Yea · 1 Nay
Party YeaNayPresentNot Voting
Democrat 13000
Republican 16100
Total 29100
% of votes cast 97%3%0%0%
How each member voted (30)
Member Party Vote
Analise Ortiz Democrat Yea
Brian Fernandez Democrat Yea
Catherine Miranda Democrat Yea
Denise “Mitzi” Epstein Democrat Yea
Eva Diaz Democrat Yea
Flavio Bravo Democrat Yea
Kiana Sears Democrat Yea
Lauren Kuby Democrat Yea
Lela Alston Democrat Yea
Priya Sundareshan Democrat Yea
Rosanna Gabaldón Democrat Yea
Sally Ann Gonzales Democrat Yea
Theresa Hatathlie Democrat Yea
Carine Werner Republican Yea
David C. Farnsworth Republican Yea
David Gowan Republican Yea
Frank Carroll Republican Yea
Hildy Angius Republican Yea
J.D. Mesnard Republican Yea
Jake Hoffman Republican Nay
Janae Shamp Republican Yea
John Kavanagh Republican Yea
Kevin Payne Republican Yea
Mark Finchem Republican Yea
Shawnna Bolick Republican Yea
Thomas "T.J." Shope Republican Yea
Timothy "Tim" Dunn Republican Yea
Venden "Vince" Leach Republican Yea
Warren Petersen Republican Yea
Wendy Rogers Republican Yea

Official roll call →

Subjects

public-safety healthcare
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors SB 1458?
SB 1458 is sponsored by Janae Shamp (Republican).
What is the current status of SB 1458?
This bill died with 57th Legislature - Second Regular Session. It reached “Passed Senate” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track SB 1458?
Track SB 1458 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 1458

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 1458

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →